Biotechnology Novartis Reveals Promising Gene Therapy Data for Treating Spinal Muscular Atrophy in Older Children – Novartis (NYSE:NVS) Read more
Biotechnology Sarepta Therapeutics’ Next-Gen Duchenne Muscular Therapy Shows Efficacy At Less Frequent Dosing – Sarepta Therapeutics (NASDAQ:SRPT) Read more